Christian Lattermann, MD
Orthopaedic Surgery · Boston, MANPI 1235118548
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Vericel Corporation at 54.9% of the total. Reporting peaked in 2023 at $26,295 and has fallen 64.8% since, to $9,259 in 2025. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $984.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vericel Corporation$44K
- Anika Therapeutics, Inc.$12K
- Linvatec Corporation$10K
- Aesculap Biologics, LLC$7K
- Joint Restoration Foundation, Inc.$3K
- Pacira Therapeutics, Inc.$2K
- plus $3K from 6 others
Across 13 payments — averaging $12,303 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Joint Restoration Foundation, Inc.$144K
- Cartiheal (2009) LTD.$7K
- Bioventus LLC$5K
- Smith+Nephew$4K
What the payments were for
- Consulting fees$39,37549%
- Speaking & faculty fees$33,92043%
- Travel & lodging$2,3473%
- Food & beverage$4,0895%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vericel Corporation | 41 | $43,801 |
| Anika Therapeutics, Inc. | 11 | $11,884 |
| Linvatec Corporation | 6 | $10,193 |
| Aesculap Biologics, LLC | 5 | $6,559 |
| Joint Restoration Foundation, Inc. | 5 | $2,830 |
| Pacira Therapeutics, Inc. | 1 | $1,875 |
| Arthrosurface Incorporated | 1 | $1,400 |
| Smith+Nephew | 6 | $591 |
| Arcuro Medical Inc | 2 | $235 |
| Miach Orthopaedics, Inc. | 1 | $180 |
| Cartiheal (2009) LTD. | 1 | $139 |
| Bioventus LLC | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$23,919
- KNEE MANUAL INSTRUMENTS$9,000
- HYALOFAST$8,725
- NOVOCART 3D$6,506
- NexoBrid$5,000
- PFXL$3,000
- HemiCAP Patella-Femoral$1,400
- LIVATEC KNEE PRESERVATION SYSTEM$1,183
- SUPERBALL$200
- AGILI-C$139
- N/A$115
- Meniscal Root Repair System$110
How this compares
$79,731 in reported general payments places this provider in the 90th percentile of 542 orthopaedic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Boston
- Paul TornettaBoston$16.3M
- Thomas ThornhillBoston$12M
- Andrew FreibergBoston$5.9M
- Jon WarnerBoston$5.4M
- Wolfgang FitzBoston$3.7M
- John KwonBoston$663K
- Christopher ChiodoBoston$539K
- Andrew WhiteBoston$438K
- Carl TalmoBoston$315K
- Michael KainBoston$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.